PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Want to see PRCT full AI Analyst Report?
Total Valuation
PROCEPT BioRobotics has a market cap or net worth of $1.63B. The enterprise value is $1.25B.
Market Cap$1.63B
Enterprise Value$1.25B
Share Statistics
PROCEPT BioRobotics has 56,918,842 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding56,918,842
Owned by Insiders4.11%
Owned by Institutions11.79%
Financial Efficiency
PROCEPT BioRobotics’s return on equity (ROE) is -0.26 and return on invested capital (ROIC) is -23.48%.
Return on Equity (ROE)-0.26
Return on Assets (ROA)-0.19
Return on Invested Capital (ROIC)-23.48%
Return on Capital Employed (ROCE)-0.23
Revenue Per Employee407.48K
Profits Per Employee-126.42K
Employee Count756
Asset Turnover0.61
Inventory Turnover1.58
Valuation Ratios
The current PE Ratio of PROCEPT BioRobotics is ―. PROCEPT BioRobotics’s PEG ratio is 10.67.
PE Ratio―
PS Ratio5.67
PB Ratio4.78
Price to Fair Value4.78
Price to FCF-29.95
Price to Operating Cash Flow-20.71
PEG Ratio10.67
Income Statement
In the last 12 months, PROCEPT BioRobotics had revenue of 308.05M and earned -95.57M in profits. Earnings per share was -1.72.
Revenue308.05M
Gross Profit196.23M
Operating Income-103.86M
Pretax Income-95.38M
Net Income-95.57M
EBITDA-97.47M
Earnings Per Share (EPS)-1.72
Cash Flow
In the last 12 months, operating cash flow was -70.13M and capital expenditures -10.43M, giving a free cash flow of -80.57M billion.
Operating Cash Flow-70.13M
Free Cash Flow-80.57M
Free Cash Flow per Share-1.42
Dividends & Yields
PROCEPT BioRobotics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change-55.77%
50-Day Moving Average25.99
200-Day Moving Average34.99
Relative Strength Index (RSI)50.13
Average Volume (3m)1.45M
Important Dates
PROCEPT BioRobotics upcoming earnings date is Jul 30, 2026, After Close (Confirmed).
Last Earnings DateApr 29, 2026
Next Earnings DateJul 30, 2026
Ex-Dividend Date―
Financial Position
PROCEPT BioRobotics as a current ratio of 6.85, with Debt / Equity ratio of 14.86%
Current Ratio6.85
Quick Ratio5.77
Debt to Market Cap0.03
Net Debt to EBITDA2.41
Interest Coverage Ratio-28.96
Taxes
In the past 12 months, PROCEPT BioRobotics has paid 190.00K in taxes.
Income Tax190.00K
Effective Tax Rate>-0.01
Enterprise Valuation
PROCEPT BioRobotics EV to EBITDA ratio is -15.52, with an EV/FCF ratio of -25.93.
EV to Sales4.91
EV to EBITDA-15.52
EV to Free Cash Flow-25.93
EV to Operating Cash Flow-30.88
Balance Sheet
PROCEPT BioRobotics has $245.64M in cash and marketable securities with $51.66M in debt, giving a net cash position of $193.98M billion.
Cash & Marketable Securities$245.64M
Total Debt$51.66M
Net Cash$193.98M
Net Cash Per Share$3.41
Tangible Book Value Per Share$6.57
Margins
Gross margin is 62.98%, with operating margin of -33.71%, and net profit margin of -31.02%.
Gross Margin62.98%
Operating Margin-33.71%
Pretax Margin-30.96%
Net Profit Margin-31.02%
EBITDA Margin-31.64%
EBIT Margin-33.71%
Analyst Forecast
The average price target for PROCEPT BioRobotics is $36.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$36.50
Price Target Upside45.19% Upside
Analyst ConsensusModerate Buy
Analyst Count11
Revenue Growth Forecast29.26%
EPS Growth Forecast-7.59%